[An article by The Conversation written by Cristine Alves Da Costa - Pharmacienne, Research Director Inserm, in charge of the ALZPARK team (Physiopathology of Alzheimer's and Parkinson's diseases) at the Institute of Molecular and Cellular Pharmacology - CNRS, Côte d'Azur University] At the heart of this cell dysfunction is a protein, l'alpha-synucleine. In a healthy brain, it plays a protective role. But in Parkinson's disease, it accumulates i…
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.
[An article by The Conversation written by Cristine Alves Da Costa - Pharmacienne, Research Director Inserm, in charge of the ALZPARK team (Physiopathology of Alzheimer's and Parkinson's diseases) at the Institute of Molecular and Cellular Pharmacology - CNRS, Côte d'Azur University] At the heart of this cell dysfunction is a protein, l'alpha-synucleine. In a healthy brain, it plays a protective role. But in Parkinson's disease, it accumulates i…